Effects of bisphenol-A (BPA), dibutylphtalate (DBP), benzophenone-2 (BP2), procymidone (Proc), and linurone (Lin) on fat tissue, a variety of hormones and metabolic parameters: A 3 months comparison with effects of estradiol (E2) in ovariectomized (ovx) rats
Introduction
It is well known that chemicals exist which interfere with hormonal signalling within the body of exposed individuals. These chemicals are called “endocrine disrupters” (EDs). An EU/WHO/OECD working group defined EDs in 1996 as follows: “An endocrine disrupter is an exogenous substance that causes adverse health effects in an intact organism, or its progeny, secondary (consequent) to changes in endocrine function. A potential endocrine disrupter is a substance that possesses properties that might be expected to lead to endocrine disruption in an intact organism.” This focuses mainly on adverse effects and it can be discussed which substance really falls under the Weybridge definition. Therefore, the term “endocrine active substance” will be used throughout the following text. Most endocrine active substances have been identified as having either estrogenic or antiandrogenic effects and therefore reproductive organs were and are still in the focus of identifying and studying the effects of most endocrine active substances (Kanno et al., 2003a, Kanno et al., 2003b, Meyer, 2003, O’Connor et al., 2002, Owens and Koeter, 2003, Yamasaki et al., 2002). Most estrogenic and antiandrogenic effects can be explained through actions via the respective steroid receptors, i.e. via the estrogen receptor (ER) α and β or the androgen receptor (AR) and these receptors are expressed in practically all cells of the body (Couse et al., 1997, Khosla and Bilezikian, 2003). Therefore, it is almost certain that endocrine active substances will have effects in other than reproductive organs. In view of the ubiquitous distribution of most nuclear receptors it was requested in several recent publications that new tests for new endpoints and new assay protocols need to become available (Ashby, 2001, Meyer, 2003). A number of organs produce specific hormones which are modulated by feedback mechanisms involving nuclear receptors. Therefore, measurement of serum hormones stemming from a variety of organs may indicate the effects of endocrine active substances within hormone-producing organs. Hence, we studied the pituitary hormones luteinizing hormone (LH), thyroid-stimulating hormone (TSH), the TSH-regulated thyroid hormone thyroxin (T4) and triiodothyronine (T3) and the ACTH-regulated adrenal corticosterone production all of which are modulated by E2 or androgens (Hochberg et al., 2003).
We have recently described a small fat depot in the lower hind leg, the “paratibial fat depot” which reacted extremely sensitive to estrogen withdrawal, i.e. to ovariectomy (ovx) by increasing its size (Seidlova-Wuttke et al., 2003) and also androgen withdrawal is known to cause fat accumulation (Bhasin, 2003a, Bhasin, 2003b). Leptin is produced by lipocytes and serum leptin values are a good indicator of the total amount of fat tissue (Ceddia et al., 2002).
Serum triglycerides are primarily stored and transported in very low density lipoproteins (VLDL) which are a hepatic product and can be hydrolized to LDLs which transport primarily cholesterol to LDL receptor containing cells and can contribute to the formation of arteriosclerotic plaques. Hence, both VLDL and LDL are aterogenic indicators. This is in contrast to the high density lipoproteins (HDL) which are formed by a number of small proteins and which transport and facilitate the transport of cholesterol from cells and blood vessels into the liver where it may be metabolised. Hence, HDL antagonize in a certain way the effects of VLDL and LDL serum cholesterol, HDL, LDL and also VLDL are E2-modulated products and determination of effects of endocrine active substances on lipoproteins may give indications whether the substances may have beneficial or adverse effects on the development of arteriosclerosis (Hozumi et al., 2000, Zammit et al., 2001).
Another hormone with great metabolic impact is T3 which is formed locally out of T4, a product of the thyroid gland under the control of pituitary TSH. Thyroid T4 production requires the activity of a thyroid peroxidase which causes iodination of tyrosin residues. The deiodination of T4 to T3 requires deiodinases which are present in many organs. Both enzyme systems are regulated by TSH (Dunn and Dunn, 2001, Nilsson, 2001).
Pituitary LH secretion is under the control of GnRH and basal levels of E2 exert a negative feedback effect on the hypothalamo/pituitary system regulating LH secretion. Therefore, estradiol and substances acting similar as E2 may exert a negative feedback effect on pituitary LH secretion in ovx animals which results in reduced serum LH levels (Ordog and Knobil, 1995).
Bisphenol-A (BPA), the chemical primarily used to produce polycarbonate plastic, and benzophenone-2 (BP2), an absorber of ultraviolet (UV) light used in many cosmetics, were shown to have estrogenic activities in that they stimulated uterine weight in ovx rats, a classical OECD-proposed test for estrogenicity (Akingbemi et al., 2004, Yamasaki et al., 2003). Dibutylphtalate (DBP) is an industrially produced plasticiser and is thereby heavily used in food packaging. Besides a questionable mild estrogenic effect DBP and several of its metabolites have antiandrogenic effects, however, without binding to the androgen receptor (Yamasaki et al., 2003) most likely by inhibiting testosterone biosynthesis. Linurone (Lin) and procymidone (Proc) have antiandrogenic effects as was shown in the Hershberger assay (Gray et al., 1999, Lambright et al., 2000, McIntyre et al., 2002, Nellemann et al., 2003, Ostby et al., 1999), i.e. in an assay measuring the weights of androgen-regulated reproductive organs such as the prostate in which both substances reduce androgen-stimulated prostate weights.
Our increasing knowledge about ERs and AR as transcription factors, their possibility to heterodimerize with splice variants and other nuclear receptors (Ferro et al., 2003, Poola et al., 2002, Resnick et al., 2000) as well as the capability of cell-specific enhancers and repressors to modulate transcriptional activity (Fleming et al., 2004, Katzenellenbogen and Frasor, 2004) enables us to understand tissue-specific effects of substances. In pharmaceutical research this has led to the concept of selective estrogen or androgen receptor modulators, so-called “SERMs” or “SARMs” (Chen et al., 2002, Katzenellenbogen and Frasor, 2004). As mentioned, ERs and AR as well as various splice variants and enhancers and repressors may be differentially expressed in various organs or even in specific cells contributing to the structure of an organ. Therefore, the possibility exists that endocrine active substances with estrogenic or antiandrogenic effects in the reproductive tract may have no estrogenic or even estrogen-antagonistic effects in organs outside the reproductive tract, for example, in hormone-producing glands or on metabolic parameters. It was therefore tempting to study the effects of the five above introduced endocrine active substances on the above introduced hormones, lipids, on the sex hormone-regulated fat depot (the paratibial fat depot), and on the gross weight of defined organs.
Section snippets
In vitro experiments
Estrogen receptor ligand-binding assay (LBA)
Subtype-specific ERα and ERβ LBAs were performed according to the recently described method of Kuiper et al. (1998) with the exception that bound and free tracer was separated by adsorption on dextran-coated charcoal as described by Jarry et al. (1985).
In vivo experiments
A total of 144 female Sprague Dawley rats were used for the present experiments. Permission to perform these experiments was obtained from the Bezirksregierung Braunschweig (permission no. Az
Results
The EC50 of the test substances, i.e. the amount of substance to displace 50% of radioactively labelled E2 bound to the ERα or the ERβ receptor are detailed in Table 2. E2 had the highest affinity to both, ERα and ERβ, that for ERβ being more than 5-fold higher than for ERα. BP2 displaced E2 from ERα and ERβ at concentrations approximately 1000-fold higher than E2 while BPA had a low affinity to ERα but a high affinity to ERβ which was only 35-fold less than E2 for the ERβ preparation. DBP
Discussion
In the present study we provide evidence for endocrine activity of a variety of substances known to be effective in the reproductive tract either with estrogenic or antiandrogenic activities. We determined first the affinities of the test substances to recombinant human ERα and ERβ protein. While the EC50 for E2 was in the low nM-range linurone and procymidone did not bind to both receptor subtypes which makes an estrogenic activity highly unlikely. Similarly, DBP did not bind to the ERα
Acknowledgement
This work was supported by the European Commission (EURISKED contract no. EVK1-CT-2002-00128).
References (55)
- et al.
Fluctuation of serum leptin level in rats after ovariectomy and the influence of estrogen supplement
Life Sci.
(1999) - et al.
Application of automatic image segmentation to tibiae and vertebrae from ovariectomized rats
Bone
(1997) - et al.
Therapeutic targeting in the estrogen receptor hormonal pathway
Semin. Oncol.
(2004) - et al.
The role of estrogens in men and androgens in women
Endocrinol. Metab. Clin. North Am.
(2003) - et al.
The obesity in bilateral ovariectomized rats is related to a decrease in the expression of leptin receptors in the brain
Biochem. Biophys. Res. Commun.
(2002) Testing and assessment strategies, including alternative and new approaches
Toxicol. Lett.
(2003)- et al.
Identification of ten exon deleted ERbeta mRNAs in human ovary, breast, uterus and bone tissues: alternate splicing pattern of estrogen receptor beta mRNA is distinct from that of estrogen receptor alpha
FEBS Lett.
(2002) - et al.
Truncated estrogen receptor product-1 suppresses estrogen receptor transactivation by dimerization with estrogen receptors alpha and beta
J. Biol. Chem.
(2000) - et al.
Endocrine active compounds affect thyrotropin and thyroid hormone levels in serum as well as endpoints of thyroid hormone action in liver, heart and kidney
Toxicology
(2004) - et al.
Pharmacology of Cimicifuga racemosa extract BNO 1055 in rats: bone, fat and uterus
Maturitas
(2003)
Pure estrogenic effect of benzophenone-2 (BP2) but not of bisphenol A (BPA) and dibutylphtalate (DBP) in uterus, vagina and bone
Toxicology
Rapid and sensitive reporter gene assays for detection of antiandrogenic and estrogenic effects of environmental chemicals
Toxicol. Appl. Pharmacol.
Low-dose in utero effects of xenoestrogens in mice and their relevance to humans: an analytical review of the literature
Food Chem. Toxicol.
Comparison of reporter gene assay and immature rat uterotrophic assay of twenty-three chemicals
Toxicology
Immature rat uterotrophic assay of 18 chemicals and Hershberger assay of 30 chemicals
Toxicology
Insulin stimulation of hepatic triacylglycerol secretion and the etiology of insulin resistance
J. Nutr.
Inhibition of testicular steroidogenesis by the xenoestrogen bisphenol A is associated with reduced pituitary luteinizing hormone secretion and decreased steroidogenic enzyme gene expression in rat Leydig cells
Endocrinology
Increasing the sensitivity of the rodent uterotrophic assay to estrogens, with particular reference to bisphenol A
Environ. Health Perspect.
Regulation of body composition by androgens
J. Endocrinol. Invest.
Effects of testosterone administration on fat distribution, insulin sensitivity, and atherosclerosis progression
Clin. Infect Dis.
Analysis of paradoxical observations on the association between leptin and insulin resistance
FASEB J.
Development of selective androgen receptor modulators and their therapeutic applications
Zhonghua Nan Ke Xue
Tissue distribution and quantitative analysis of estrogen receptor-alpha (ERalpha) and estrogen receptor-beta (ERbeta) messenger ribonucleic acid in the wild-type and ERalpha-knockout mouse
Endocrinology
Update on intrathyroidal iodine metabolism
Thyroid
Biphasic modulation of pituitary sensitivity to GnRH by oestrogens: the effects of A- and D-ring substitution on LH release in cultured pituitary cells
Acta Endocrinol. (Copenhagen)
Alternative splicing of the human estrogen receptor alpha primary transcript: mechanisms of exon skipping
Int. J. Mol. Med.
Differential recruitment of coregulator proteins steroid receptor coactivator-1 and silencing mediator for retinoid and thyroid receptors to the estrogen receptor-estrogen response element by beta-estradiol and 4-hydroxytamoxifen in human breast cancer
J. Clin. Endocrinol. Metab.
Cited by (72)
Benzophenone-2 exerts reproductive toxicity in male rats
2023, Reproductive ToxicologyDibutyl phthalate disrupts conserved circadian rhythm in Drosophila and human cells
2021, Science of the Total EnvironmentEffects of bisphenol A at the safe reference dose on abdominal fat deposition in aged hens
2020, Ecotoxicology and Environmental SafetyEffects of butylparaben exposure on thyroid peroxidase (TPO) and type 1 iodothyronine deiodinase (D1) in female Wistar rats
2020, ToxicologyCitation Excerpt :Study of Seidloν’a-Wuttke et al. (2005) also reported no probable association of E2 exposure on TPO activity of OVX rats after giving average daily intake of 1.2 mg of E2/kg BW. Hence, in our study the modulations of TPO activity after treatment with BP can be explained by the biphasic nature of effect of E2 or estrogen like substances as reported by the previous researchers; the low dose of E2 stimulated TPO activity significantly, while high dose of E2 showed no effect (Seidloν’a-Wuttke et al., 2005; Lima et al., 2006). In the current study we found a direct relationship between serum TSH level and TPO activity in thyrocytes of rats treated with BP.